Clinical Trials Directory

Trials / Completed

CompletedNCT05952544

Effect of Protein Restriction Plus EAA/KA Supplementation on GFR Decline in CKD

Does Protein Restriction Plus Essential Amino Acids and Keto-analogues Supplementation Have a Beneficial Effect on GFR Decline in CKD Patients?

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the effect of protein restriction plus KA/EAA supplementation on GFR decline in CKD patients.

Detailed description

In chronic kidney disease (CKD) patients, ketoacid analogues of essential amino acids (KA/EAA) are administered to reduce the production of harmful metabolic products and enhance nutritional status. Protein restriction combined with AA supplement may have beneficial effects on CKD in several ways, by reducing nitrogen waste, oxidative stress, and inflammation, and by protecting against hemodynamic changes in glomerular hyperfiltration. several clinical trials have documented that very low protein diets (VLPD) supplemented with KA/EAA preserve the rate of progression of advanced CKD. However, in long-term follow-up of the MDRD study, VLPD plus KA/EAA treatment did not delay progression to dialysis or transplantation. As a result, no firm conclusions have been drawn on the effectiveness of protein-restricted diets combined with KA/EAA supplements in retarding CKD progression.

Conditions

Interventions

TypeNameDescription
DRUGessential amino acids and keto-analogues supplementationvery low protein diet plus essential amino acids and keto-analogues supplementation
OTHERlow protein dietpatients were on low protein diet only

Timeline

Start date
2023-07-20
Primary completion
2024-03-30
Completion
2024-05-15
First posted
2023-07-19
Last updated
2024-08-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05952544. Inclusion in this directory is not an endorsement.